# Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)

> **NCT00885794** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00885794
- **Lead sponsor:** The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-05
- **Final completion:** 2012-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885794, "Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00885794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*